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gene cluster may underlie cognitive deficits
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Maria V Sanchez-Vives6,7 and Mara Dierssen1,2,3*Abstract
Addiction involves long-lasting maladaptive changes including development of disruptive drug-stimuli associations.
Nicotine-induced neuroplasticity underlies the development of tobacco addiction but also, in regions such as the
hippocampus, the ability of this drug to enhance cognitive capabilities. Here, we propose that the genetic locus of
susceptibility to nicotine addiction, the CHRNA5/A3/B4 gene cluster, encoding the α5, α3 and β4 subunits of the
nicotinic acetylcholine receptors (nAChRs), may influence nicotine-induced neuroadaptations. We have used transgenic
mice overexpressing the human cluster (TgCHRNA5/A3/B4) to investigate hippocampal structure and function in
genetically susceptible individuals. TgCHRNA5/A3/B4 mice presented a marked reduction in the dendrite complexity of
CA1 hippocampal pyramidal neurons along with an increased dendritic spine density. In addition, TgCHRNA5/A3/B4
exhibited increased VGLUT1/VGAT ratio in the CA1 region, suggesting an excitatory/inhibitory imbalance. These
hippocampal alterations were accompanied by a significant impairment in short-term novelty recognition memory.
Interestingly, chronic infusion of nicotine (3.25 mg/kg/d for 7 d) was able to rescue the reduced dendritic complexity,
the excitatory/inhibitory imbalance and the cognitive impairment in TgCHRNA5/A3/B4. Our results suggest that chronic
nicotine treatment may represent a compensatory strategy in individuals with altered expression of the CHRNA5/A3/B4
region.
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It is now generally accepted that addiction represents a
neuropathology of learning and memory [1]. Drugs of
abuse, including nicotine, induce neuroplasticity in areas
involved in cognitive function, such as the hippocampus,
a neuroadaptation assumed to contribute to the develop-
ment of addiction by favoring associative memories
[2-6]. These neuroadaptations occur at the level of neur-
onal structure and synaptic strength and also underlie
the effects of the drug on cognitive performance [7-11].* Correspondence: mara.dierssen@crg.es
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unless otherwise stated.In the case of nicotine addiction, two of the most com-
mon withdrawal symptoms are both changes in affection
and cognition, which, during periods of abstinence from
smoking, predict relapse [12]. Nicotinic acetylcholine re-
ceptors (nAChRs) are the main targets of nicotine. They
also play a significant role in cognition and its disruption
has been demonstrated in numerous psychiatric and
neurological disorders that present cognitive alterations,
including schizophrenia [13], attention deficit hyper-
activity disorder [14] or Alzheimer’s disease [15]. All
these neuronal disorders exhibit defects in the dendritic
architecture of hippocampal pyramidal neurons and ex-
citatory/inhibitory synaptic connectivity in the hippo-
campus, which are considered to play critical roles in
cognitive function and dysfunction [16-18]. Hence, under-
standing the genetic influences on the effects of nicotinetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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nicotine addiction treatment, although this area of re-
search is relatively new.
However, not all individuals develop addiction to to-
bacco [19,20], nor the effects of nicotine on cognitive
function are equal across human populations [21,22], sug-
gesting that changes induced by nicotine consumption
may be different in susceptible individuals. The CHRNA5/
A3/B4 gene cluster encoding the α5, α3 and β4 subunits
of the nAChRs [23] is the major genomic locus associated
with nicotine dependence in humans [24,25]. This region
has also been linked to reduced levels of performance in
cognitive domains such as response inhibition, attention
and discriminative abilities [26,27]. Interestingly, Zhang
et al. [28] demonstrated that current smoking corrects the
increased perseverative errors and responses associated
with this cluster in a cognitive flexibility test battery. These
findings in human individuals support the view that some
nicotine-dependent subjects may become addicted as a
means of self-medication [29], explaining the fact that to-
bacco use is more prevalent and intense in human popula-
tions that manifest cognitive alterations [22].
We here tested the hypothesis that the CHRNA5/A3/B4
cluster could modify the development of tobacco addiction
and cognitive function by influencing neuroplasticity in the
hippocampus, one of the few brain regions that expresses
the α5, α3 and β4 nAChR subunits [30-36]. To this end,
we used a BAC transgenic mouse model overexpressing
the human CHRNA5/A3/B4 gene cluster (TgCHRNA5/A3/
B4), which exhibit increased sensitivity to the pharmaco-
logical effects of nicotine [37], along with increased binding
sites for nicotinic agonists in hippocampal membrane
preparations [38] and hippocampal slices, particularly in
the CA1 region [37]. We provide evidence that the overex-
pression of the CHRNA5/A3/B4 region has an effect on
the dendritic architecture of hippocampal pyramidal neu-
rons, on the excitatory/inhibitory balance and on recogni-
tion memory. These structural and functional alterations
in transgenic mice are rescued upon chronic nicotine
administration.
Materials and methods
Animals
Transgenic mice overexpressing the human gene cluster
CHRNA5/A3/B4 (TgCHRNA5/A3/B4) [37] were obtained
from crosses of TgCHRNA5/A3/B4 males and B6/SJL-F1J
females. Two transgenic TgCHRNA5/A3/B4 lines (L30
and L22; see our previous work [37]) were generated and
showed no differences in their phenotype, excluding the
possibility that the phenotypic profile of TgCHRNA5/A3/
B4 and their response to nicotine might be attributed to
the transgene insertion sites. In all experiments wild type
(WT) littermates served as controls. Adult male mice (2–
3 months of age) were group housed with 3–5 animals percage under a 12 h light/dark schedule, in controlled
environmental conditions of humidity (50–70%) and
temperature (21 ± 1°C), with food and water supplied ad
libitum. All experimental procedures were approved by
the local ethical committee (CEEA - PRBB), and met the
guidelines of the local (Catalan law 5/1995 and Decrees
214/97, 32/2007) the European regulations (EU directives
86/609 and 2001–486) and the Standards for Use of La-
boratory Animals A5388-01 (NIH).
Drug administration
(−)-Nicotine hydrogen tartrate was purchased from
Sigma-Aldrich (St. Louis, MO). For the in vivo studies,
animals were subcutaneously implanted with Alzet os-
motic minipumps (Model 2001) (Alzet, Cupertio, CA)
under O2 – isofluorane mixture anesthesia. Each mini-
pump contained either saline (0.9% NaCl) or nicotine
solutions (3.25 mg/Kg/d, free base) and delivered a con-
stant subcutaneous flow in a rate of 1 μl/1 h. The con-
centration of nicotine was adjusted to compensate for
body weight differences among subjects. This nicotine
administration regime gives rise to sustained plasma
nicotine concentrations similar to that reached in heavy
smokers [39] and induces physical dependence in mice
[40]. For the in vitro studies, (−) - nicotine was dissolved
in fresh medium (3.25 μM, free base) and hippocampal
primary cultures received medium alone or containing
nicotine for 48 h.
Histological analysis
All mice were deeply anesthetized with isofluorane and per-
fused with 0.1M phosphate buffer saline (PBS) followed by
4% paraformaldehyde (PFA, Sigma, St. Louis, MO). Mice
were sacrificed on the seventh day after minipump implant-
ation; the brains were removed and sliced at Bregma - 1.34
mm to - 2.18 mm.
Morphometry of hippocampal pyramidal neurons
We used intracellular injections of Lucifer yellow (LY,
L0259; Sigma, St. Louis, MO) [41,42]. Briefly, 150 μm
thick vibratome-sliced sections were prelabeled with 4,6-
diamidino-2-phenylindole (D9542; Sigma) and neurons
from dorsal CA1 hippocampus were injected with LY by
continuous current (n = 5–10 cells/animal; 4 – 5 animals/
group from ≥ 3 experiments). After injecting the neurons,
sections were first processed with anti-LY antibody made
in rabbit (1:10 000, Sigma, L9163, in stock solution: 2%
bovine serum albumin [A3425; Sigma], 1% Triton X-100
[30632; BDH Chemicals, Poole, UK], and 5% sucrose in
PBS) and then with a biotinylated donkey anti-rabbit sec-
ondary antibody (1:200 in stock solution; RPN1004;
Amersham Pharmacia Biotech, Little Chalfont, UK).
Immunolabeled cells were visualized with Alexa Fluor
488-conjugated streptavidin (1:1000 in PBS, Invitrogen).
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tire apical dendrite arbor was completely filled were in-
cluded in the analysis. Images were acquired at 40 x with a
LSM 710 Zeiss confocal microscope equipped with laser
excitation at 488 nm (Carl Zeiss MicroImaging GmbH,
Germany) and each image was a z series projection of over
100 stacks, taken at 1 μm depth intervals. Individual neur-
onal apical arbors were three-dimensionally (3D) recon-
structed using Neurolucida software (MicroBrightField,
Inc., Vermont, USA) and morphometric analysis was per-
formed using Neuroexplorer software (MicroBrightField,
Inc., Vermont, USA) [43]. This module opens an image
stack of confocal images and allows the measurement of
several morphological parameters of dendritic arborisa-
tion. The following parameters were analysed: Sholl ana-
lysis (branching complexity, measured as the number of
dendritic intersections within concentric 10 μm radial
spheres, calculated as a function of distance from the
soma), total number of nodes, total dendritic length, den-
dritic volume (the volume of a neuron’s apical dendritic
field calculated as the volume enclosed by a polygon cre-
ated by joining the most distal points of the dendritic pro-
cesses, the 3D convex Hull volume) [44].
To further investigate neuronal structure of pyramidal
neurons, TgCHRNA5/A3/B4 males were crossed with
Thy1-YFP (Yellow Fluorescent Protein) heterozygous fe-
males (B6.Cg-Tg (Thy1-YFPH) 2Jrs/J; Jackson Laborator-
ies) and obtained double transgenic mice that expressed
YFP sparsely in subsets of pyramidal neurons. Brains
were extracted as described before, postfixed with 4%
PFA and cryoprotected with 30% sucrose. A vibratome
(Leica, Wetzlar, Germany) was used to obtain coronal
sections (150 μm thick). Fluorescent images were obtained
with a SP5 confocal microscope (Leica, Wetzlar, Germany)
and analyzed by ImageJ software. The number of basilar
(stratum oriens) and apical (stratum radiatum) dendritic
structures of CA1 pyramidal neurons was determined
within a 50 × 50 μm2 area in a single plane images ac-
quired at 40 × (n = ≥100 images animal; 4–5 animals/
group from ≥ 3 experiments). The dendritic spine density
of CA1 pyramidal neurons was quantified along 30 μm
length sections of primary and secondary dendrites, at
50 μm from the cell soma and, expressed as number of
spines per 10 μm (n = 5–10 cells/animal; 4–5 animals/
group from ≥ 3 experiments). Spine count was per-
formed on images acquired at 63 × with 2.0 × (optical
zoom), generating a stack from 9 – 10 images, taken at
0.36 μm depth intervals. Dendritic spines were sepa-
rated on morphological categories as previously de-
scribed (stubby, mushroom-like, thin or filopodia) [45].
The number of pyramidal cells per CA1 and CA3 areas
was quantified on images acquired at 20 × and taken at
different x, y and z coordinates to visualize the entire
hippocampus. Each image was a z series projection ofapproximately 10–12 stacks, and taken at 5 μm depth
intervals.
Immunohistochemistry
Vesicular glutamate transporter (VGLUT1) and vesicu-
lar GABA transporter (VGAT) were used as markers
for excitatory and inhibitory synaptic inputs [46]. 40
μm thick coronal sections were obtained from brains
extracted as described before, using a cryostat (Leica,
Wetzlar, Germany). Samples were permeabilized with
0.1M PBS 0.5% Triton X-100 (PBST) (Sigma, St. Louis,
MO), and blocked in 20% fetal bovine serum (FBS)
PBST, for 1 h at room temperature (RT). Samples were
incubated with the primary antibodies anti-VGLUT1
(mouse, 1:200, Synaptic Systems, Goettingen, Germany)
and anti-VGAT (guinea pig, 1:200, Synaptic Systems,
Goettingen, Germany), in 5% FBS PBST, overnight at
4°C. After washes in PBST, they were incubated with
secondary fluorescently labeled antibodies (Alexa ®Fluor
488 and Alexa ®Fluor 594, Life Technologies, Grand
Island, NY) in 5% FBS PBST for 1 h, at RT. Images
were acquired with SPE Confocal Microscope (Leica,
Wetzlar, Germany), connected to the LAS AF software
(Leica, Wetzlar, Germany), and analyzed using Image J soft-
ware. Background was subtracted from negative control
values of each sample and the same threshold was applied
for each channel. The number of VGLUT1 and VGAT
puncta was quantified within a 20 × 20 μm2 region of the
CA1 strata oriens and radiatum on single plane images ob-
tained at 63 × with 5.0 × (optical zoom) (n = ≥100 images
animal; 4–5 animals/group from ≥ 3 experiments).
Electrophysiological recordings
Field excitatory postsynaptic potentials (fEPSPs) were re-
corded in the stratum radiatum of dorsal hippocampal
CA1 region in response to stimulation of the Schaffer col-
lateral (SC) pathway (n = 3–5 recordings/animal; 4 – 5 an-
imals/group from ≥ 3 experiments). Mice were sacrificed
by decapitation on the seventh day after minipump im-
plantation, the brain was quickly removed and placed on
ice-cold cutting solution (in mM): 2.5 KCl; 3 MgSO4; 1.25
NaHPO4; 1 CaCl2; 26 NaHCO3; 10 sucrose and aerated
with 95% O2 – 5% CO2 to a final pH of 7.4. Coronal slices
(400 μm thick) were obtained with a vibratome (Leica,
Wetzlar, Germany); placed in an interface style recording
chamber (Fine Science Tools, Foster City, CA) and bathed
in artificial cerebrospinal fluid (ACSF) containing (in
mM): 124 NaCl; 2.5 KCl; 1 MgSO4; 1.25 NaHPO4; 2.5
CaCl2; 26 NaHCO3; and 10 dextrose aerated with 95%
O2–5% CO2 to a final pH of 7.4. Bath temperature was
maintained at 32 – 34°C. Unfiltered recordings were ob-
tained by means of ACSF-filled glass electrodes (imped-
ance 1–2 MΩ) through a Neurolog system (Digitimer)
amplifier. Electrical stimuli were delivered using a stimulus
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FL) with a concentric monophasic bipolar electrode
(200-μm-diameter ultra-small concentric bipolar elec-
trode; Frederick Haer Co., Bowdoinham, ME). Stimulus
strength was adjusted to a stimulation intensity that
yielded a half-maximal response (50–150 μA). For each
slice, after establishing a stable response (electrical stimu-
lation at 0.03 Hz), paired-pulse facilitation (PPF) was
induced by a double-pulse (50 ms apart) stimulation
protocol. PPF is a short-term presynaptic phenomenon
that at SC-CA1 synapses it is inversely related to the prob-
ability of neurotransmitter release [47]. Long-term potenti-
ation (LTP) was induced by a high frequency stimulation
protocol (HFS; 100 Hz; 1 s) 20 min after baseline recor-
ding. Responses were recorded for a period of 60 min
(pulse at 0.03 Hz) and the magnitude of LTP was measured
by averaging the percent increase of the fEPSP slope com-
pared with baseline. Recordings were acquired, digitized,
and analyzed using a data acquisition interface and soft-
ware from Cambridge Electronic Design (Spike2).
Cell culture
Hippocampal primary cultures were obtained from WT
and TgCHRNA5/A3/B4 mice at embryonic day 17.5 - 18.5
(n = 4 independent experiments, 3–4 cultures/condition
from ≥ 3 experiments). Cultures were obtained from indi-
vidual embryos; no pool of material was mixed. Hippo-
campi were dissected on ice-cold Dulbecco’s Modified
Eagle Medium (DMEM) (Life Technologies, Grand Island,
NY). Cells were mechanically dissociated, centrifuged and
resuspended in 0.5 ml Neurobasal culture medium, supple-
mented with 2% B27 factor, 1% Glutamax, 0.5% Penicillin/
Streptomycin (NB+++) and 10% Inactivated Horse Serum
(all reagents were supplied from Life Technologies, Grand
Island, NY). Neurons were seed at a density of 5 × 104 cells
per well on round glass coverslips and, incubated under
culture conditions of 37°C and 5 %CO2. 24 h after plating,
the serum was removed and substituted by NB+++ to avoid
massive glial proliferation. To analyze the morphology of
pyramidal neurons, at day-in-vitro (DIV) 5, cultures were
transfected with a plasmid containing enhanced green
fluorescent protein (EGFP) driven by the Thy1 promoter
(designed and kindly provided by Dr. G. Ramakers, Univer-
sity of Amsterdam), by means of Lipofectamine 2000 (Life
Technologies, Grand Island, NY) and following manufac-
turer instructions. At DIV7, half of the plate received fresh
medium alone or containing nicotine for 48h. All the mor-
phological and biochemical studies were performed in
DIV9 cultures fixed in PFA 4% for 20 min at RT. The den-
dritic complexity of pyramidal neurons was examined in
non-overlapping positive cells expressing EGFP, by means
of Sholl analysis (n = 4–5 cells/culture, 3–4 cultures/con-
dition from ≥ 3 experiments). Images were acquired with a
SP5 Confocal Microscope (Leica, Wetzlar, Germany),connected to the LAS AF software (Leica, Wetzlar,
Germany), using a 63x objective generating a z - stack
from 7–9 images taken at a 0.5 μm depth interval, and at
different x, y and z coordinates to visualize the entire
neuron. For spine count on transfected neurons, images
were acquired at 63 × with 2.0× (optical zoom), generating
a stack from 9–10 images taken at a 0.36 μm depth inter-
val. Spines were quantified along 30 μm length sections of
primary and secondary dendrites at a distance of 50 μm
from the cell soma, and expressed as number of spines per
10 μm of dendrite length (n = 4 – 5 cells/culture, 3–4 cul-
tures/condition from ≥ 3 experiments). To examine gluta-
matergic and GABAergic inputs in the neuronal cultures,
immunofluorescence labeling against VGLUT1 and VGAT
markers was performed as describe above. The number of
VGLUT1 and VGAT puncta per 10 μm of dendrite was
determined within a region of 50 μm proximal to the cell
body of neurons, with aids of Image J software (n = 4 –
5 cells/culture, 3 – 4 cultures/condition from ≥ 3 experi-
ments). To assess the viability of the cultures at DIV9,
neurons were incubated with 3-(4,5-dimethyolthiazol-2-
yl)-2,5-diphenyltetrazlium bromide (MTT, 500 μg/ml,
Sigma, St. Louis, MO) in 0.1M PBS for 30 min, at 37°C
and, under dark conditions. After incubation, the medium
was removed and formazan dye was extracted using 100%
detergent sodium dodecyl sulfate (DMSO, Sigma, St. Louis,
MO). The absorbance was determined using a microplate
reader at 550 nm (n = 4–5 wells/culture, 3–4 cultures con-
dition from ≥ 3 experiments).
Behavioral analysis
Adult male mice were allowed to habituate to the testing
room under dim light for at least 30 min. Animals (n =
10–12 mice/group from ≥ 3 experiments) were subjected
for novel object recognition memory paradigm on the
fourth day after minipumps were implanted. Mice that
underwent behavioral tests were never used for histo-
logical or electrophysiological analysis.
Novel object recognition (NOR)
The apparatus consisted of a rectangular open-field
arena (70 cm long × 70 cm wide × 30 cm high) made of
Plexiglas, surrounded by curtains to avoid the influence
of external stimuli during the experiment. Animals’ behav-
ior was monitored using System Motor Activity Record
and Tracking software (SMART, Panlab Harvard Appar-
atus, Spain). On the first day, mice were habituated to the
arena for 10 min. On the second day, mice were presented
with two identical objects, for 10 min. Subjects failing to
complete a minimum of 20 s of exploration during the
familiarization session were excluded for posterior ana-
lysis. In a 1 h delay (test session), mice were presented
with one familiar object and a novel one, for 5 min. The
discrimination index was calculated as time exploring the
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of exploration *100 [48]. Exploratory behavior was defined
as the animal directing its nose towards the object at a dis-
tance of < 2 cm and manually registered by the experi-
menter. Sitting on or resting against the object was not
considered as exploration. All the objects used were plas-
tic made and induced similar exploration levels. The arena
and objects were deeply cleaned between animals to avoid
olfactory cues. Anxiety-like behavior was measured as per-
centage of time spent in the periphery of the open field.
Statistical analyses
All data are presented as mean ± standard error of mean
(SEM). Genotype comparison was performed by Stu-
dent’s T test. Two-way analysis of variance (ANOVA)
was used for genotype and treatment analysis. When the
interaction of genotype x treatment was significant a
Bonferroni post hoc test was used as a correction be-
tween pair wise comparisons. Otherwise, the significant
effect of genotype or treatment was taken into consider-
ation. Repeated measure ANOVA was used for the Sholl
analysis. All statistical analyses were performed using
Statistical Package for the Social Sciences (SPSS) soft-
ware (version 19.0).
Results
CHRNA5/A3/B4 overexpression leads to a reduced
dendritic complexity in CA1 hippocampal pyramidal
neurons that is rescued by nicotine treatment
Using Lucifer Yellow (LY) injections and neuronal recon-
struction techniques, we detected a reduction in the com-
plexity of the apical dendritic tree in TgCHRNA5/A3/B4
CA1 pyramidal neurons, compared to WT (p = 0.019,
Figure 1a-b, Sholl analysis), with decreased number of
nodes (p < 0.001, Additional file 1: Figure S1a). This de-
crease of branching complexity in transgenic neurons was
found only in the proximal region of the apical dendrite,
which corresponds to the portion of dendrite mainly re-
ceiving excitatory input from CA3 connections, but not in
the distal part receiving input from the temporoammonic
pathway [49]. Transgenic CA1 pyramidal neurons pre-
sented reduced total dendrite length (p = 0.014) and total
dendrite volume (p = 0.016, Additional file 1: Figure S1b-c).
We next investigated if a chronic nicotine treatment in
the adult brain affects the dendritic complexity of CA1
pyramidal neurons. To address this question, we used
transgenic animals expressing YFP in pyramidal neurons
(Thy1-YFP-WT and Thy1-YFP-TgCHRNA5/A3/B4 mice)
implanted with saline or nicotine (3.25 mg/Kg/d) for
7 d. In saline-treated Thy1-YFP TgCHRNA5/A3/B4 mice
we again observed a significant reduction in the number
of proximal apical dendrites (p < 0.001) and in the prox-
imal portions of basal dendrites (p < 0.001) (Figure 1c-d).
Chronic nicotine treatment in Thy-YFP-TgCHRNA5/A3/B4mice rescued this phenotype and increased the num-
ber of basal (p = 0.007) and apical dendrites (p < 0.001)
(Figure 1c-d), but reduced both the number of basal
(p < 0.001) and apical dendrites (p < 0.001) in Thy-YFP-WT
mice (Figure 1c-d). No differences in the number of pyra-
midal cell somas per area in the CA1 stratum pyramidale
layer were detected between genotypes or treatment groups
(Additional file 2: Figure S2a).
Dendritic spine density in CA1 pyramidal neurons
increases in WT and TgCHRNA5/A3/B4 mice upon chronic
nicotine treatment
Thy1-YFP-WT and TgCHRNA5/A3/B4 mice treated with
either saline or nicotine (3.25 mg/Kg/d for 7 d) were
used to examine whether the altered dendritic branching
in CA1 pyramidal neurons was accompanied with chan-
ges in dendritic spines. Basal dendrites from transgenic
neurons did not show differences in total dendritic
spines as compared to WT (Figure 1e-f ). Nevertheless,
they presented an increase in the proportion of stubby
spines (p < 0.001) along with a non-significant reduction
of thin spines (Table 1). In contrast, apical dendrites of
Thy1-YFP-TgCHRNA5/A3/B4 pyramidal neurons pre-
sented increased density of total dendritic spines, as
compared to WT (p < 0.001, Figure 1e-f ). Morphological
analysis of spines indicated that, similar to the spines of
basal dendrites, this increase was mainly due to in-
creased density of stubby spines (p = 0.039) but also of
mushroom-like (p = 0.01) (Table 1).
Chronic nicotine treatment increased the density of
mushroom-like spines on apical dendrites (p = 0.05,
Table 1), without changing the total dendritic spine
density, in both Thy1-YFP-WT and Thy1-YFP-TgCHRN-
A5/A3/B4 mice (Figure 1e-f ). However, nicotine did
not affect spine densities in CA1 pyramidal basal den-
dritic tree.
Reduced excitatory and inhibitory synaptic inputs in the
CA1 region of TgCHRNA5/A3/B4 mice are normalized
upon chronic nicotine administration
In the mature brain, most glutamatergic synapses occur at
dendritic spines [45,50]. Thus, the differences observed in
dendritic spines might be associated with changes in the
density of excitatory synaptic inputs in the CA1 region.
To explore this possibility, we immunostained hippo-
campal slices from saline or nicotine treated WT and
TgCHRNA5/A3/B4 mice using VGLUT1, a commonly
used neuronal marker for presynaptic glutamatergic synap-
ses in the mouse hippocampus [51].
TgCHRNA5/A3/B4 exhibited decreased VGLUT1
puncta in strata radiatum (p < 0.001) and oriens (p <
0.001) (Figure 2a-b) that was restored to control
values upon chronic nicotine administration (3.25 mg/
Kg/d for 7 d), being the restoration more pronounced
Figure 1 CA1 pyramidal neurons structure in mice overexpressing the CHRNA5/A3/B4 region and upon chronic nicotine treatment.
(a) Representative reconstructions of the apical dendritic tree of Lucifer Yellow transfected wild type (WT, upper panel) and TgCHRNA5/A3/B4 neurons
(Tg, lower panel), Scale bar 25 μm. (b) Sholl analysis indicated that transgenic neurons showed reduced number of dendritic intersections compared to
WT, particularly at 50 to 150 μm from the cell soma (n = 5–10 cells/animal; 4–5 animals/group from≥ 3 experiments). (c) Representative confocal
images of the CA1 region in Thy1-Yellow Fluorescent Protein (YFP) - WT and Tg mice that received either saline (Sal) or nicotine (Nic, 3.25 mg/Kg/d) for
7 d, Scale bar 25 μm. (d) Quantification of the number of apical and basal dendritic structures in 50 × 50 μm2 area revealed significant reductions in
Sal-treated Thy1-YFP-Tg mice, compared to Sal-treated Thy1-YFP-WT mice. Chronic administration of nicotine restored the dendritic deficit in Thy1-YFP-
Tg mice but instead the same treatment reduced the number of dendritic structures in Thy1-YFP-WT mice (n =≥100 images animal; 4–5 animals/group
from≥ 3 experiments). (e) Representative photomicrograph illustrating dendritic spines on apical dendrites in CA1 pyramidal neurons from saline and
nicotine treated Thy1-YFP- WT and Tg mice, Scale bar 10 μm. (f) Quantification of spines per 10 μm of dendrite length indicated that apical but not
basal dendrites from saline- and nicotine-treated Thy1-YFP-Tg mice presented increased spines as compared to Thy1-YFP-WT (n = 5–10 cells/animal; 4–5
animals/group from≥ 3 experiments). *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001; Two-way ANOVA genotype effect σσ p≤ 0.01.
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(Figure 2a-b). In contrast, the same treatment had op-
posite effects in WT animals, leading to a loss of gluta-
matergic inputs in the CA1 region (stratum radiatum
p < 0.001; stratum oriens p < 0.001, Figure 2a-b).
When examining the density of inhibitory synapses
(VGAT puncta), we found similar results, since TgCHRNA5/Table 1 Effects of nicotine on dendritic spines in CA1 pyramid
Apical dendrites
Spines per 10 μm Stubby Mushroom-like Th
WT Sal 0.90±0.12 10.94±0.45 0.
WT Nic 0.79±0.17 11.83±0.65ω 0.
Tg Sal 1.50±0.23σ 12.20±0.39σ 0.
Tg Nic 0.96±0.15σ 13.51±0.70σ,ω 0.
Number of spines per 10 μm of dendrite length, in apical and basal dendrites of CA
A3/B4 (Tg). Mice were implanted with osmotic minipumps delivering either saline (S
(n = 5–10 cells/animal; 4–5 animals/group from ≥ 3 experiments). Two-way ANOVA gA3/B4 showed significantly reduced GABAergic inputs
(stratum radiatum p < 0.001, stratum oriens p < 0.001,
Figure 2c-d). However, the reduction of VGAT exceeded the
reductions of VGLUT1 puncta and thus, the ratio of glu-
tamatergic vs. GABAergic input was increased in the CA1
region of TgCHRNA5/A3/B4mice, causing an E/I imbalance
(stratum radiatum p= 0.004, stratum oriens p= 0.007,al neurons from adult mice
Basal dendrites
in Stubby Mushroom-like Thin
27±0.08 0.84±0.09 10.30±0.65 0.03±0.02
08±0.06 0.86±0.12 10.10±0.58 0.00±0.00
23±0.10 1.16±0.11σ 10.01±0.62 0.01±0.01
11±0.06 1.40±0.13σ 9.74±0.61 0.00±0.00
1 pyramidal neurons from Thy1-YFP-wild type (WT) and Thy1-YFP-TgCHRNA5/
al) or nicotine (Nic, 3.25 mg/Kg/d) for 7 d
enotype effect σp ≤ 0.05, treatment effect ωp ≤ 0.05.
Figure 2 Glutamatergic and GABAergic puncta and their ratio in the hippocampal CA1 region. (a) Representative confocal images of
VGLUT1 immunostaining in the stratum oriens (SO) of wild type (WT) and TgCHRNA5/A3/B4 (Tg) mice that received either saline (Sal) or nicotine
(Nic, 3.25 mg/Kg/d) for 7 d, Scale bar 5 μm. (b) Quantification of VGLUT1 puncta showing that Tg mice presented reduced glutamatergic puncta in SO
and stratum radiatum (SR), as compared to their WT littermates. Chronic infusion of nicotine rescued the reduced density of VGLUT1 puncta in the CA1
SO of Tg mice, but caused opposite effects in WT, leading to a significant decrease both in SO and SR. (c) Representative confocal images of VGAT
immunostaining in the SO of mice with the conditions indicated, Scale bar 5 μm. (d) Quantification of VGAT puncta showing reduced GABAergic input
in SO and SR of Tg mice, compared to WT. Chronic nicotine increased VGAT puncta in SO in Tg. In contrast, the same treatment reduced VGAT puncta
in SO and SR in WT mice. (e) The glutamatergic (Glu)/GABAergic ratio in CA1 SO and SR regions was increased in Tg mice, as compared to WT.
Chronic nicotine treatment rescued the increased Glut/GABA ratio in Tg, with no effect in WT (n =≥100 images animal; 4–5 animals/group from≥ 3
experiments). *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001.
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http://www.actaneurocomms.org/content/2/1/147Figure 2e). In all groups of mice the density of GABAergic
input was higher in stratum radiatum than in stratum oriens
(Figure 2c), reflecting a greater inhibitory regulation in this
region, as previously described [52]. Chronic nicotine nor-
malized the density of GABAergic inputs in TgCHRNA5/
A3/B4 (p = 0.002, Figure 2c-d) and compensated for their
E/I imbalance (stratum radiatum p = 0.003; stratum oriens
p = 0.039, Figure 2e). Conversely, chronic nicotine reduced
GABAergic inputs in WT mice (stratum radiatum
p < 0.001; stratum oriens p = 0.006, Figure 2c-d), but
without modifying their E/I balance (Figure 2e). The
treatment did not modify the density of CA3 pyramidal
neurons neither in WT nor in TgCHRNA5/A3/B4 mice,
the major excitatory inputs in the CA1 region (Additional
file 2: Figure S2b).
Chronic nicotine enhances HFS-induced LTP at SC-CA1
connections in WT and TgCHRNA5/A3/B4 mice
We further interrogated whether differences in excitatory
and inhibitory synapses described above could underliechanges in synaptic strength, such as LTP responses, con-
sidered the cellular substrate of memory function [53]. To
this aim, we recorded fEPSPs in the CA1 stratum radiatum
region evoked by HFS (100 Hz, 1 s) applied to SC afferents.
Recordings were performed in slices from WT and
TgCHRNA5/A3/B4 animals treated with saline or chronic
nicotine (3.25 mg/Kg/d for 7 d). The results showed that
HFS stimulation to SC amplified the degree of CA1 synap-
tic potentiation along the 60 min of recordings, similarly in
slices from saline-treated TgCHRNA5/A3/B4 and WT mice
(Figure 3a-b). Additionally, using paired pulse facilitation
(50 ms apart) no differences were observed between geno-
types in release probability (Figure 3c).
Chronic nicotine administration reduced the threshold
for LTP induction at SC-CA1 pathway (Figure 3a-b). Slices
from mice that received the drug treatment elicited in-
creased synaptic potentiation immediately upon stimula-
tion (at 15 min post HFS, p = 0.002, Figure 3b) that was
maintained for more than 45 min (p = 0.009, Figure 3b).
Noticeably, the effects of nicotine on LTP induction were
Figure 3 Electrically induced synaptic plasticity of Shaffer collateral-CA1 pathway. (a) High frequency stimulation (HFS; 100Hz, 1s) induced
synaptic potentiation at Schaffer Collateral (SC)-CA1 synapses similarly in slices from saline (Sal)-treated wild type (WT) and TgCHRNA5/A3/B4 (Tg) mice.
Chronic nicotine (Nic, 3.25 mg/Kg/d) administration for 7 d enhanced synaptic potentiation both in WT and Tg mice. Upper panel: representative field
excitatory postsynaptic potentials (fEPSPs) in response to one stimulation in the CA1 stratum radiatum before (1) and 15 min after (2) applying HFS
(arrow), Scale bar 0.5 mV and 1 ms. Lower panel: slopes of the fEPSPs normalized to those obtained before applying HFS (%). (b) Mean values of fEPSPs
potentiation at 15 and 45 min after HFS. (c) The paired pulse ratio (fEPSP2/fEPSP1) with an inter-pulse interval of 50 ms (response average of 5 paired
pulses; time interval 1 s) was similar among slices from the different experimental conditions (n = 3–5 recordings/animal; 4 – 5 animals/group from≥ 3
experiments). Two-way ANOVA treatment effect ωω p≤ 0.01.
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http://www.actaneurocomms.org/content/2/1/147similar between genotypes. Moreover, chronic nicotine
had no significant effect on paired pulse facilitation
(Figure 3c).Reduced dendrite arborization of cultured TgCHRNA5/A3/B4
hippocampal neurons is rescued by nicotine
The morphological features of pyramidal neurons in the
brain are influenced by the anatomical connections with
other structures. To dissociate these histological effects
we used primary cultures and investigated the structure
of hippocampal pyramidal neurons in TgCHRNA5/A3/
B4 and their response to nicotine in more controlled
conditions. Thy1-EGFP transfected hippocampal primary
cultures from WT and TgCHRNA5/A3/B4 embryos were
exposed for 48h to basal medium (control) or medium
with nicotine (3.25 μΜ).
Similar to the adult mouse tissue, the dendritic com-
plexity of cultured hippocampal pyramidal neurons from
transgenic embryos was significantly reduced compared
to WT cultures (p = 0.004, Figure 4a-b, Sholl analysis). In
transgenic pyramidal neurons, we also detected increased
density of immature filopodia-like structures compared to
WT neurons (p = 0.007), while no significant changes were
detected in other spines subtypes (Table 2) or the density
of total dendritic spines (Figure 4c-d). Cultures fromtransgenic embryos also presented a significant reduction
in GABAergic inputs (VGAT puncta) (p = 0.025, Figure 4f),
but no changes in glutamatergic input (VGLUT1 puncta)
(Figure 4e), confirming that overexpression of the CHRN
A5/A3/B4 cluster causes a significant decrease of GABAer-
gic input.
Again, nicotine differentially affected the dendritic
complexity and presynaptic inputs depending on the
genotype. Sholl analysis revealed that while nicotine
was able to restore the dendritic complexity in trans-
genic neurons (p = 0.002), the same treatment caused
detrimental effects on WT cultures reducing the den-
dritic arborization (p = 0.009, Figure 4a-b, Sholl ana-
lysis). Nicotine exposure did not modify the density of
glutamatergic inputs neither in WT or transgenic cul-
tures (Figure 4e), but reduced stubby spines (p = 0.033),
without affecting filopodia and mushroom-like spines
(Table 2) or the total spine density (Figure 4c-d). How-
ever, nicotine reduced VGAT puncta in control cul-
tures (p = 0.025), while it had no effect in transgenic
cultures (Figure 4f ). The MTT control assay revealed
no significant differences among groups (WT control
1.00 ± 0.00; WT nicotine 0.84 ± 0.123; TgC HRNA5/A3/
B4 control 1.39 ± 0.297; TgCHRNA5/A3/B4 nicotine
1.24 ± 0.251), indicating that the viability of the culture
was not affected by the nicotine exposure.
Figure 4 Pyramidal neurons structure in hippocampal primary cultures. (a) Photomicrograph illustrating positive Thy1-Enhanced Green
Fluorescent Protein (EGFP) pyramidal neurons from wild type (WT) and TgCHRNA5/A3/B4 (Tg) cultures exposed to medium alone (Control, Ct) or
containing nicotine (Nic, 3.25 μM) for 48 h, Scale bar 25 μm. (b) Sholl analysis revealed reduced number dendritic complexity in neurons from Tg cultures,
as compared to WT. Chronic exposure to nicotine rescued the reduced dendritic complexity in Tg cultures. In contrast, in WT cultures the same treatment
reduced the dendritic arborisation. (c) Photomicrograph illustrating dendritic spines in EGFP transfected neurons from the experimental conditions
indicated, Scale bar 2 μm. (d) Quantification of spines per 10 μm of dendrite length showed no differences among groups. Quantification of the number
of (e) VGLUT1 and (f) VGAT puncta per 10 μm of dendrite length in cultures from the experimental conditions indicated. No differences in VGLUT1 puncta
were detected among groups. Instead, VGAT puncta were reduced in Tg, as compared to WT cultures. Nicotine treatment reduced VGAT inputs only in
WT but not in Tg cultures (n = 4–5 cells/culture; 3 – 4 cultures/condition from≥ 3 experiments). *p≤ 0.05, **p≤ 0.01.
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mice is rescued upon chronic nicotine treatment
Finally, we examined to what extent TgCHRNA5/A3/B4
presented an altered cognitive performance and if so,
what was the effect of the chronic nicotine treatment
(Figure 5a). In humans, single nucleotide polymorphismsTable 2 Effects of nicotine exposure on dendritic spines
in pyramidal neurons from hippocampal primary cultures
Spines
per 10 μm
Filopodia Stubby Mushroom-like Thin
WT Ct 0.56±0.15 2.23±0.72 12.05±1.44 1.00±0.24
WT Nic 0.93±0.22 0.94±0.29ω 12.82±1.32 1.75±0.37
Tg Ct 1.61±0.35σ 1.18±0.34 10.96±0.86 1.72±0.31
Tg Nic 2.29±0.68σ 0.65±0.23ω 12.21±2.21 2.32±0.44
Number of spines per 10 μm of dendrite length, in neurons from wild type
(WT) and TgCHRNA5/A3/B4 (Tg) embryos. Cultures were incubated with
medium alone (Ct, Control) or containing nicotine (Nic, 3.25 μM) for 48 h
(n = 4–5 cells/culture; 3 – 4 cultures/condition from ≥ 3 experiments). Two-way
ANOVA genotype effect σ p ≤ 0.05, treatment effect ω p ≤ 0.05.within the CHRNA5/A3/B4 locus have been associated
with reduced performance in cognitive tasks requiring
discriminative abilities. In the sense that carriers of the
nicotine addiction risk allele present difficulties in work-
ing memory and attention and in maintaining and up-
dating information over short delays [27]. In rodents,
the hippocampus plays a significant role in discrimin-
ation memory [54], while intra-hippocampus infusion of
nAChRs agonists facilitate recognition memory [55]. We
found that saline-treated TgCHRNA5/A3/B4 mice ex-
hibited impaired short-term novelty recognition mem-
ory, as compared to WT. During the test session of
the novel object recognition paradigm, they showed a
similar exploration rate towards the familiar and novel
objects as compared to WT (Additional file 3: Figure
S3a). As a consequence, the discrimination index was sig-
nificantly reduced in TgCHRNA5/A3/B4 mice, compared
to saline-treated WT littermates (p = 0.008, Figure 5c).
During this recognition session, no differences were
Figure 5 Short-term novel object recognition memory. (a) Drug administration protocol used during the novel object recognition (NOR) task
(Hab, Habituation session; Fam, Familiarization session; Test session). (b) Saline (Sal)-treated TgCHRNA5/A3/B4 (Tg) mice presented a significant
impairment in recognition memory, as compared to wild type (WT) littermates, as shown by reduced discrimination index which was expressed
as [(time exploring the novel object – time exploring the familiar object)/total time of exploration*100]. Chronic administration of nicotine (Nic,
3.25 mg/kg/d) for 5 d rescued the impaired recognition memory in Tg mice, but had no effect in WT (n = 10–12 animals/group from≥ 3
experiments). *p≤ 0.05, **p≤ 0.01.
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anxiety-like behavior (Additional file 3: Figure S3b-c).
Chronic nicotine did not affect novelty recognition mem-
ory in WT animals, but it completely reversed the impaired
short-term novel object recognition memory in saline-
treated TgCHRNA5/A3/B4 mice (p = 0.035, Figure 5c). The
treatment reduced the time that transgenic mice spent ex-
ploring the familiar object, while increased the exploration
time for the novel object (Additional file 3: Figure S3a).
Both WT and TgCHRNA5/A3/B4 receiving the drug
showed similar amounts of exploration and anxiety-like
behavior, as compared to saline-treated mice (Additional
file 3: Figure S3b-c).Discussion
The present study demonstrates that the CHRNA5/A3/
B4 gene cluster contributes to defining the dendritic
complexity of hippocampal pyramidal neurons, the exci-
tatory and inhibitory inputs in the hippocampus and
novelty recognition memory. Moreover, deregulation of
this genomic region modifies the effects of a chronic
nicotine treatment on hippocampal neuroplasticity and
cognitive function.
Overexpression of the CHRNA5/A3/B4 cluster in mice
leads to a significant reduction in the dendritic arborization
of CA1 pyramidal neurons. Morphological reconstructions
using Lucifer Yellow injections and genetically driven Thy-YFP expression in mice revealed that pyramidal neurons of
TgCHRNA5/A3/B4 show a reduced total dendritic tree
length, volume and branching, resulting in decreased target
space. Our morphological analysis also revealed a higher
proportion of stubby spines on both apical and basal den-
drites in transgenic pyramidal neurons. Stubby spines are
considered immature forms of spines in the adult brain
[56] and an increased proportion in TgCHRNA5/A3/B4
support the view that overexpression of the CHRNA5/A3/
B4 cluster impairs spine maturation. Moreover, immuno-
staining results for the presynaptic marker VGLUT1
showed that excitatory synaptic inputs in CA1 strata
radiatum and oriens in TgCHRNA5/A3/B4 are reduced.
Spines lacking synaptic inputs are thought to be less
stable in time [57], and thus may explain the increased
immature spines in TgCHRNA5/A3/B4. Intriguingly, our
results resemble those observed in CA1 pyramidal neu-
rons of mice lacking the α7 nAChR subunit (α7KOs) that
show reduced dendritic complexity along with increased
dendritic spine density [58]. However, although α7KOs
lack glutamatergic synapses in the CA1 region, they show
no changes in GABAergic synapses [51]. This contrasts
our data, since TgCHRNA5/A3/B4 show reduced inhibi-
tory inputs in CA1 strata radiatum and oriens along with
an increased ratio of glutamatergic/GABAergic inputs.
Loss of inhibition and hippocampal hyper-excitability has
been associated with reduced growth of dendritic arbors
[59], and delayed maturation and stability of dendritic
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A3/B4 cannot be attributed to reduced α7-nAChRs since
our previous studies showed normal levels of α7-nAChRs
on the hippocampus [38]. Interestingly, α3 nAChR subunit
is increased in the hippocampus of α7KOs [60], thus sug-
gesting that the phenotype of α7KOs could be interpreted
as a consequence of a α3-nAChRs overexpression.
Disrupted dendritic arbor and spines in the CA1 pyram-
idal neurons usually are assumed to impair synaptic efficacy
in this region [61,62]. Nevertheless, electrophysiological
recordings demonstrated that applying HFS to the SC affer-
ents elicits similar degree of CA1 synaptic potentiation in
transgenic hippocampal slices. The PPR is also similar be-
tween genotypes, suggesting no change in release probabil-
ity. In the CA1 region, nAChRs containing the α5, α3 or β4
subunits are mainly found on stratum radiatum interneu-
rons [30,32], where they control pyramidal cell soma and
apical dendritic tree excitability. Nevertheless, they are also
expressed by pyramidal neurons [33]. nAChRs play a sig-
nificant role in the expression of LTP in the CA1 [7,63] and
it may be possible that increased nAChRs in CA1 region of
TgCHRNA5/A3/B4 [37] contribute to synaptic efficacy in
SC-CA1 connections, overcoming the detrimental structure
of CA1 pyramidal neurons.
Because in our transgenic model the overexpression of
the cluster CHRNA5/A3/B4 occurs since fertilization
[37], the overall structural and network connectivity al-
terations detected in TgCHRNA5/A3/B4 could arise
from early development. Our studies in cultured hippo-
campal neurons support this idea since transgenic neu-
rons develop with a less complex dendritic tree, higher
proportions of immature filopodia-like structures and
also deficits in GABAergic inputs. Recent observations
have shown an important role of α5-nAChRs during de-
velopment. Thus, mice lacking the α5 subunit (α5KOs)
lose a dendritic pruning of apical dendrites in developing
cortical pyramidal neurons [64]. This would suggest that
the reduced dendritic branching in TgCHRNA5/A3/B4
could be the result of excessive pruning driven by α5-
nAChRs. The loss of pruning in α5KOs has been associ-
ated with attentional deficits in these mutant mice [64,65].
We found impaired short-term recognition memory in
our TgCHRNA5/A3/B4 that may also be related with this
cognitive role of α5-nAChRs. In humans, genetic varia-
tions within the CHRNA5/A3/B4 cluster are associated
with lower discriminative abilities and with an increase in
the levels of nAChRs expression [27]. In rodents, the novel
object recognition paradigm is the best suited to study dis-
criminative abilities. Performance in the novel object
recognition test depends on the hippocampus and the
perirhinal cortex, and in fact, the activation of nAChRs in
both regions facilitates recognition memory [55]. More-
over, the same genetic variations have also been associated
with decreased functional connectivity strength in corticaland subcortical circuits, including the hippocampus,
shown by functional magnetic resonance imaging stu-
dies [66]. Thus, it may be conceivable that CHRNA5/
A3/B4 overexpression induces alterations in the peri-
rhinal cortex, but this is less probable due to the low
levels of expression of the α3, α5 and β4 nAChRs sub-
units in this region [67,68].
Next we investigated how the CHRNA5/A3/B4 region
influences the effects of nicotine on hippocampal plas-
ticity. Our findings demonstrate that chronic nicotine ex-
posure differentially shapes the dendritic tree of CA1
pyramidal neurons in TgCHRNA5/A3/B4 and WT mice. In
WT mice, chronic nicotine treatment significantly reduces
the number of basal and apical dendrites. Previous studies
have observed similar effects on hippocampal morphology
but upon developmental exposure to nicotine [69,70]. Re-
markably, the effects of nicotine are opposite in TgCHR
NA5/A3/B4, in which nicotine increases arborization com-
pletely rescuing the reduced dendritic complexity. Similar
to our results, in α5KOs, nicotine treatment also compen-
sates their pruning defect and abnormal increase of den-
dritic branching in developing cortical neurons, while the
same treatment causes opposite effects in control animals
[71]. This suggests that α5-nAChRs may contribute to the
differential response to nicotine observed in TgCHRNA5/
A3/B4. Recent studies have demonstrated that genetic fac-
tors define different effects of cocaine in modifying the den-
dritic arbor of CA1 pyramidal neurons. Drug-induced
plasticity in dendritic complexity is higher in rats prone to
development of drug addiction [72]. Both TgCHRNA5/
A3/B4 and α5KO mice show increased nicotine self-
administration, as compared to control mice [37,73,74].
Whether the differential response to nicotine on dendritic
arborization could be linked to development of nicotine
addiction requires further investigation.
We also found that chronic exposure to nicotine in-
creases the density of mushroom-like spines in apical den-
drites of CA1 pyramidal neurons in both genotypes and
compensates for the reduced proportion of stubby versus
mushroom-like spines in TgCHRNA5/A3/B4. However, im-
munostaining experiments showed that chronic nicotine
treatment induces differential genotype effects on presynap-
tic excitatory and inhibitory inputs. In WT mice, nicotine
reduces both VGAT and VGLUT1 presynaptic inputs but
does not affect the E/I balance. This is in contradiction with
previous work reporting that nicotine increases only gluta-
matergic synapses in the CA1 region, without changing
GABAergic synapses [51]. Differences in the dose of nico-
tine used, duration of the treatment and the age of ani-
mals could explain these discrepancies. Conversely, in
TgCHRNA5/A3/B4 mice, chronic nicotine normalizes the
reduced glutamatergic and GABAergic presynaptic inputs
and restores the E/I imbalance. The experiments in primary
cell cultures confirmed that overexpression of CHRNA5/
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and presynaptic VGAT puncta. A differential response to
GABA in TgCHRNA5/A3/B4mice may require further in-
vestigation, given the important role of GABA during the
development of nicotine addiction [75].
The electrophysiological recordings revealed that chronic
nicotine treatment facilitates LTP induction at SC-CA1
pathway, in agreement with previous published data
[76-78]. Nevertheless, this effect was similar in both geno-
types. Since nicotine enhances LTP responses via nAChRs
containing the β2 subunit [79], it seems likely that this re-
sponse to nicotine is not altered in our TgCHRNA5/A3/B4.
According to other authors [80], we found that chronic
nicotine treatment has no impact on recognition memory
in WT animals. Interestingly, the same treatment restores
the impairment in recognition memory in TgCHRNA5/
A3/B4mice, similar to what has been described in humans
with genetic mutations in this cluster [28].
In summary, in this study we provide new evidence that
the overexpression of the CHRNA5/A3/B4 region disrupts
pyramidal neuronal structure in the hippocampus, and
thus affecting the cognitive capacities. The present work
also demonstrates that CHRNA5/A3/B4 overexpression
modifies nicotine-induced changes on dendritic architec-
ture, presynaptic excitatory/inhibitory inputs and re-
cognition memory, but not on synaptic potentiation.
Understanding how the CHRNA5/A3/B4 locus drives the
effects of nicotine may help to develop new therapeutic
strategies for the pathogenesis of tobacco addiction.Additional files
Additional file 1: Figure S1. Morphological analysis of the dendritic
tree in Lucifer Yellow transfected CA1 pyramidal neurons. The apical
dendritic tree of TgCHRNA5/A3/B4 (Tg) showed reduced total number of
dendrite nodes (a), length (b) and volume (c), as compared to wild type
(WT) mice (n = 5–10 cells/animal; 4–5 animals/group from≥ 3 experiments).
*p≤ 0.05, ***p≤ 0.001.
Additional file 2: Figure S2. Number of pyramidal somas per area in
the CA1 and CA3 layers. Thy1-yellow fluorescent protein (YFP)-wild type (WT)
and Thy1-YFP- TgCHRNA5/A3/B4 (Tg) mice that received either saline (Sal) or
nicotine (Nic, 3.25 mg/Kg/d) for 7 d showed similar number of pyramidal
cell somas per area in stratum pyramidale (SP) CA1 and CA3 layers (n =≥100
images animal; 4–5 animals/group from≥ 3 experiments).
Additional file 3: Figure S3. Novel object recognition test session.
TgCHRNA5/A3/B4 (Tg) mice spent similar amount of time (s) exploring the
familiar and novel objects, as compared to their wild type (WT)
littermates. Chronic administration of nicotine (Nic, 3.25 mg/Kg/d) for 5 d
increased the time that Tg spent exploring the novel object while
reduced the time exploring the familiar object, in comparison to Tg that
received saline (Sal) (a). No differences were observed among the four
groups of animals in total time of exploration (b) and, time spent in the
periphery and centre of the open field (%) (c) along the 5 min duration
session (n = 10–12 animals/group from ≥ 3 experiments).Competing interests
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